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We investigated the direct action of angiotensin II (Ang II) on myocardial conduction
and transmembrane action potential immediately after reoxygenation.
Method: After superfusion in a simulated ischemic solution, ventricular papillary muscle
preparations of rat heart were washed with oxygenated Tyrode solution containing Ang II,
Ang II plus CV-11974 (an AT1 receptor blocker), or Ang II plus 5-hydroxydecanoic acid
(mito-KATP blocker), under rapid electrical stimulation (RES) for 60 s.
Results: In the control experiments, the incidence of conduction delay and block was the
highest within the ﬁrst 10 s, and subsequently, 1:1 conduction was established after 40 s.
Ang II signiﬁcantly enhanced the 2:1 conduction block during the later phase of RES (40–60 s
after reoxygenation). This effect of Ang II was abolished by either CV-11974 (Po0.001)
or 5-HD (Po0.001).
Conclusion: RES-induced conduction delay and block immediately after reoxygenation
were accelerated by Ang II, which could be relevant to the maintenance of reperfusion
arrhythmias. The mito-KATP channel may participate in the mechanism underlying this
phenomenon.
& 2012 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
Multiple randomized trials (such as the Valsartan in
Acute Myocardial Infarction trial: VALIANT) have demon-
strated that angiotensin II receptor blockers (ARBs), as
well as the angiotensin-converting enzyme (ACE) inhibitor
captopril, reduce mortality and cardiovascular morbidity
among patients with myocardial infarction complicated by
left ventricular systolic dysfunction [1]. In the canine
heart, reperfusion arrhythmias (RAs) are usually sudden
in onset and deteriorate to ventricular ﬁbrillation (VF)
within 5–30 s, and instantaneous VF (onset at 0–1 min) is
known to occur in the midst of the recovery process, whenrt Rhythm Society. Publish
. Wakatsuki).electrical heterogeneity is increased [2]. Acute adminis-
tration of an ACE inhibitor and an ARB increases the
threshold of VF, which suppresses RA [3,4]. The intracor-
onary delivery of low doses of ACE inhibitor suppresses RA
after primary percutaneous coronary interventions for
acute myocardial infarction [5]. On the basis of these
ﬁndings, it is hypothesized that angiotensin II (Ang II)
has a direct accelerating action on the generation of RAs
during the super-acute phase of reperfusion (within 60 s
of reperfusion), in addition to its well-known, long-term
action, which is termed remodeling [6]. However, the
short-term direct electrophysiological action of Ang II at
the cellular level during the super-acute phase of reperfu-
sion has not been clariﬁed.
The purpose of this study was (1) to develop an
experimental system for recording successive transmem-
brane action potentials (APs) and activation times (ATs)
during rapid electrical stimulation (RES) of small tissueed by Elsevier B.V. All rights reserved.
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evaluate the direct action of Ang II on the mode of
myocardial conduction and the shape of APs immediately
after reoxygenation.
2. Methods
2.1. Preparations and recording techniques
The investigation conformed to the Guide for the Care
and Use of Laboratory Animals put forth by the U.S.
National Institutes of Health, and the experimental pro-
cedures were approved by the Showa University Institu-
tional Animal Care and Use Committee. Male Wistar
Kyoto rats (WKYIzm), weighing 350–400 g, were anesthe-
tized with sodium pentobarbital (50 mg/kg, intraperito-
neal injection), and the heart was quickly removed. The
heart was placed in normal Tyrode solution bubbled
with oxygen to extract the blood by spontaneous
beatings. A piece of the left ventricular papillary muscle
(PPM) attached to the ventricular free wall was dissected
out and mounted on a Lucite superfusion chamber with
an effective volume of 1.5 mL. Papillary muscle specimens
were superfused with oxygenated normal Tyrode solution
(3 mL/min) and bubbled with 95% O2 and 5% CO2 at a
temperature of 3770.2 1C. The composition of the Tyrode
solution was as follows (in mM): NaCl, 137.0; NaH2PO4,
1.8; NaHCO3, 12.0; MgCl2, 0.5; KCl, 5.4; CaCl2, 1.8;
and glucose, 5.5. The pH of the solution was adjusted to
7.2–7.3. Equilibration time of least 30 min was allowed to
obtain stable recordings.Fig. 1. Experimental set-up and transmembrane action potential recording. A photo
chamber is shown in panel A. A schematic representation of the experimenta
division; EG: 50 mV/division. Abbreviations: AP: transmembrane action potentia
EP: electrical pulse; P: pin to ﬁx the preparation; St.E: modiﬁed bipolar stimulThe experimental set-up is shown in Fig. 1. As shown
in the schema in panel C, the ventricular free wall at the
root of the PPM was pinned (indicated by P) at the bottom
of the chamber, and the tip of the PPM was ligated with a
silk thread, which was gently pulled to ﬁx the prepara-
tion. The preparation was stimulated with a 1-Hz elec-
trical current applied at the root of the PPM, with an
intensity equal to twice the threshold value and a pulse
duration of 2 ms. The pulses were delivered to the pre-
paration by modiﬁed bipolar electrodes. Panel C (circular
inset) shows the enlarged schema of the tip of the
electrodes. When the internal core of this electrode is
charged with the cathode and contacts the surface of the
specimen and the impulse propagation through the PPM
surface is stabilized, the AT can be properly measured
even from small specimens, such as rat PPM. The glass
microelectrodes were ﬁlled with 3 M KCl and had tip
resistances of 2075 MO. The microelectrodes were con-
nected to a high-impedance DC ampliﬁer with input
capacity neutralization (MEZ 3000; Nihon Kohden, Co.
Ltd., Tokyo, Japan) and used to measure AP. AT was
determined as the interval between the end of the
stimulating pulse and the maximum upstroke velocity at
phase 0 (dV/dtmax) of the AP. The microelectrode was
impaled into a myocardial cell at the tip of the PPM, 3 mm
away from the stimulating electrode (St.E). To obtain the
electrogram (EG) and suppress excessive movements of
the PPM, a circular tungsten wire was placed at the tip of
the PPM, as shown in panel A. An indifferent silver wire
electrode was placed on the opposite side of the PPM. The
EG, shaped as qR, is shown in panel A. The ﬁrst segment,graph of the papillary muscle (PPM) ﬁxed on the bottom of a superfusion
l set-up is shown in panel C. Units: AP: 20 mV/division; dV/dt: 50 V/s/
l; dV/dt: upstroke velocity of the AP; E: chamber earth; EG: electrogram;
ating electrodes.
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of the PPM to the endocardial site of the dissected left
ventricular wall. The second segment, R, indicates the
spread of myocardial conduction through the PPM. The
AP, dV/dt, and EG shown on the oscilloscope screen were
captured as animations (frame rate, 33/s) using a DVD
recorder (DZ-MV580 WOOO; Hitachi, Co. Ltd., Tokyo,
Japan). A representative frame of the animation is shown
in panel B. Excitation–conduction properties could be
evaluated using this model. In addition, these electrical
signals were digitized and inputted into a Windows-based
PC using the software LEG-1000 (Nihon Kohden, Co. Ltd.)
for subsequent analysis.
2.2. Experimental protocol
After the AP, dV/dt, and EG were measured as control
recordings, a simulated ischemic solution saturated
with 95% N2 and 5% CO2 and containing high potassium
and low glucose concentrations was introduced into
the chamber at a ﬂow rate of 2 mL/min for 5 min at
3770.2 1C. The composition of the simulated ischemic
solution was as follows (mM): NaCl, 137.0; NaH2PO4, 1.8;
NaHCO3, 12.0; MgCl2, 0.5; KCl, 8.0; CaCl2, 1.8; and glucose,
0.5. After exposure to the simulated ischemic solution for
5 min, the preparations were perfused with oxygenated
normal Tyrode solution for 5 min. The 5 different types of
Tyrode solutions (including control) used during reoxy-
genation were as follows: (1) normal Tyrode solution
(control; n¼12); (2) normal Tyrode solution containing
Ang II (108 M; Sigma Chemical Co., St. Louis, USA;
n¼10); (3) normal Tyrode solution containing Ang II plus
CV-11974, the active form of candesartan (107 M;
Takeda Pharmaceutical Inc., Osaka, Japan; n¼10); (4)
normal Tyrode containing Ang II plus PD123319, a selec-
tive AT2 receptor blocker (10
7 M; Sigma Chemical Co;
n¼5); and (5) normal Tyrode solution containing Ang II
plus 5-hydroxydecanoic acid, a mito-KATP channel blocker
(5-HD, 106 M; Sigma Chemical Co., St. Louis, USA; n¼12)
[7]. The concentrations of Ang II and candesartan were
selected on the basis of their effective doses in clinical
practice.
During the ﬁrst 60 s after reoxygenation, PPM prepara-
tions were stimulated at high frequency (8–10 Hz); this
period was set such that it was 20 ms longer than the
functional refractory period of the preparation under
normal Tyrode solution. After RES for 60 s, the prepara-
tions were stimulated again at 1 Hz for 4 min. The AP,
dV/dt, and EG were recorded at 0, 1, 2, 3, and 5 min after
reoxygenation.
2.3. Analyses of data
The data were captured as a DVD movie, played back
on a computer screen frame-by-frame, and edited using
the appropriate PC software (Adobe Premiere Elements
3.0, Adobe Systems Inc., San Jose, CA). Representative
stationary pictures were clipped at optional time points
and enlarged, and their parameters measured manually.
The frames recorded during RES were divided into 60 equal
segments (1 segment¼1 s). We investigated whetherconduction block was present in each segment, and the
total number of segments with conduction block was
counted.
2.4. Statistical analysis
All measurements are shown in terms of mean and SD.
Statistical signiﬁcance among 3 or 4 groups were evalu-
ated by one-way analysis of variance (ANOVA) followed
by Tukey’s test. Differences between 2 groups were
determined using a two-sided paired t-test, and a differ-
ence with Po0.05 was considered signiﬁcant.
3. Results
3.1. Activation time and conduction mode after
reoxygenation
A representative example of the time courses of AT and
AP during the ﬁrst 60 s after reoxygenation is shown in
Fig. 2. In this ﬁgure, the clipped frames (A–E) from the DVD
movie demonstrate AT changes in the control experiment.
The baseline recorded before simulated ischemia is shown
in frame A, which shows an AT of 4.2 ms. Frame B shows the
recording at the beginning of RES. AP, dV/dt, and EG were
reduced. AT was prolonged from 4.2 to 11.2 ms. Approxi-
mately 2 to 3 s later, the PPM preparation was abruptly non-
responsive to RES, as shown in frame C. From 6 to 20 s after
reoxygenation, AT was alternately shorter (frame D-1) and
longer (frame D-2) since the 2:1 conduction block occurred
repeatedly (AT alternans). After this, gradual restoration of
normal AP, dV/dt, and EG was observed, with simultaneous
recovery of the prolonged AT and conduction block up to
60 s after reoxygenation. Subsequently, AT returned to the
baseline, as shown in frame E. When Ang II was added to
the perfusate after reoxygenation, the pattern of AT change
after reoxygenation was not much different from that of the
control, but the conduction block was increased until the
end of RES. However, when both Ang II and CV-11974 were
added to the perfusate, the increase in the conduction block
observed during perfusion with Ang II alone disappeared.
In the case of perfusion with Ang II plus 5-HD, the AT
was less prolonged from 0 to 20 ms after reoxygenation, but
the 2:1 conduction block did not appear. In addition, the
time-dependent changes in AT and the appearance of the
conduction block during perfusion with Ang II plus
PD123319 (n¼5) did not differ signiﬁcantly from that of
the control.
Continuous records of AP and EG during RES are shown
in Fig. 3. Continuous records showing 2:1 conduction
are observed in panel A. The transition from 2:1 to 1:1
conduction is illustrated in panel B, and continuous
records showing 1:1 conduction are illustrated in panel C.
The feet of AP and EG, highlighted by a square frame in
panel A, are enlarged in panel D. The 2:1 conduction was
accompanied by small negative EG deﬂections (arrow-
heads) and local responses (stars), as highlighted in
panel D.
Fig. 4 indicates the percentage incidences of conduc-
tion block during 60 s of RES (sum of the time (s) of
observed conduction block/60 s100). Graph A shows
Fig. 2. Changes in activation time during rapid electrical stimulation after reoxygenation for 60 s. Changes in transmembrane action potential (AP), dV/dt,
electrogram (EG), and activation time (AT) in a control experiment are shown. Frame A shows the baseline record before simulated ischemia. Frame B
shows the recording at the beginning of reoxygenation. In frame C, AP was abruptly non-responsive for electrical stimulation, 3 s after reoxygenation.
Prolonged AT and AT alternans (D-1 and D-2) are shown in frame D. Frame E shows the recording 60 s after reoxygenation. Abbreviations: AT: activation
time; AP: transmembrane action potential; dV/dt: ﬁrst derivative of action potential; EG: electrogram.
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course of RES in the control (n¼10), Ang II (n¼7), Ang II
plus 5-HD (n¼8), and Ang II plus CV-11974 (n¼8) groups.
The incidence of conduction block in the Ang II plus 5-HD
group (9%) was signiﬁcantly lower (Po0.001) than those
in the control (95%) and Ang II (99%) groups. The inci-
dence of conduction block in the Ang II plus CV-11974
group (49%) was signiﬁcantly lower (Po0.001) than those
in the control and Ang II groups. Graph B shows the
incidences of conduction block in 20 s of RES in both the
control and the Ang II group. The incidence of block over
the 60-s time course progressively decreased in the
control group and increased higher in the Ang II group.
During the last 20 s, conduction block was continuously
observed in the Ang II group (100%), and its incidence was
signiﬁcantly higher (Po0.05) than that in the control
group (88%). Furthermore, in the Ang II plus CV-11974
group, the conduction block was notably suppressed in
the last 20 s (Po0.001, Ang II vs. Ang II plus CV-11974;
data not shown).Changes in the mean AP duration from 0 to 60 s after
reoxygenation in the normal Tyrode solution (gray
squares; n¼8) and Ang II (black squares; n¼8) under
RES are shown in Fig. 5. The vertical axis shows the mean
percentages of AP durations (APD50: 50% repolarization
duration) as compared to APD50 at 0 s after reoxygenation.
The mean baseline value of APD50 was 17.1 ms. The mean
APD50 at 19 s after reoxygenation was signiﬁcantly longer
with Ang II than with the control (Po0.05). Other than
this, no signiﬁcant differences between the 2 groups were
found at any time point after reoxygenation. The APD50
gradually increased to 15–20% at 60 s in both groups.
3.2. AT and action potential amplitude from 1 to 5 min after
reoxygenation
Table 1 shows the measured values of the parameters
before and after simulated ischemia/reoxygenation. Per-
cent changes in the AT and AP amplitude (Amp) from 1 to
5 min after reoxygenation are presented in Fig. 6. In order
Fig. 3. Continuous records of transmembrane action potential and electrograms under rapid electrical stimulation immediately after reoxygenation. Panel A: 2:1
conduction. Panel B: transition from 2:1 to 1:1 conduction. Panel C: 1:1 conduction. Panel D: enlarged tracing of the feet of action potentials and
electrograms highlighted in panel A. Local responses of action potentials are indicated by the star, and the corresponding local electrograms are indicated
by arrows. Abbreviations: AP: transmembrane action potential; EG: electrogram; RES: rapid electrical stimulation.
Fig. 4. Incidence of conduction blocking during rapid electrical stimulation from 0 to 60 s after reoxygenation. (A) shows the percentage of conduction block
during the ﬁrst 60 s after reoxygenation in the control (white; n¼10), Ang II group (gray; n¼7), Ang II plus CV-11974 group (black; n¼8), and Ang II
plus 5-HD group (light vertical stripes; n¼8). B shows the time-dependent change in the incidences of conduction block in the control (n¼10) and the
Ang II group (n¼7). All measurements are shown in terms of mean and SD. Abbreviations: Ang II: angiotensin II; CB: conduction block; 5-HD:
5-hydroxydecanoate; NS: not signiﬁcant; nnPo0.001, control or Ang II vs. Ang II plus 5-HD; ##Po0.001, control or Ang II vs. Ang II plus CV-11974 in
graph A; Po0.05, control vs. Ang II in graph B.
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ditions, the changes in AT and Amp were represented as the
ratio of the baseline values to the values observed after
simulated ischemia and reoxygenation. The graphs illustratethe changes in the AT and Amp ratios during simulated
ischemia/reoxygenation. The preparations were superfused
with simulated ischemic solution for 5 min (Is-5). After
5 min, the simulated ischemic solution was replaced with
Fig. 5. Change in the mean action potential duration under rapid electrical
stimulation during the ﬁrst 60 s after reoxygenation. Abbreviations: Ang II:
under Tyrode solution containing angiotensin II (108 M); APD50: 50%
repolarization duration; control: under normal Tyrode solution during
reoxygenation. nPo0.05, control vs. angiotensin II.
Table 1
Changes in the measured values of parameters before and after simu-
lated ischemia/reoxygenation.
Baseline R-0 R-l R-5
AT (unit: ms)
Control 6.371.8 11.875.0 10.072.4 6.871.7
Ang II 5.071.1 11.274.1 10.874.1 6.872.3
Ang IIþCV 5.071.6 9.673.5 7.373.6 4.371.4
Ang IIþ5HD 5.171.6 8.673.3 7.772.1 6.071.5
Amp (unit: mv)
Control 79.2714.3 54.3721.0 52.2723/6 75.8722.9
Ang II 79.3713.5 57717.6 52.8715.5 72.8722.2
Ang IIþCV 80.277.3 35.6712.2 52.4714.0 74.3716.2
Ang IIþ5HD 81710.9 59.8713.8 64.2716.8 78.2712.3
AT: activation time; Amp: amplitude of transmembrane action potential,
R-0, R-1, and R-5 at 0, 1, and 5 min after reoxygenation, respectively.
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delivered to the preparation was changed from 1 Hz to RES
for 60 s. Subsequently, the preparations were superfused
with normal Tyrode solution for 5 min (R-5). The mean AT
ratio in each group for the period of 1 to 5 min after
reoxygenation (R-1 to R-5) is illustrated in the left graph.
The mean AT ratios of both Ang II plus 5-HD and Ang II plus
CV-11974 groups were signiﬁcantly higher than those of the
Ang II group at 1, 2, and 3min after reoxygenation (R-1, R-2,
and R-3, respectively). In other words, the recovery of AT in
both groups was signiﬁcantly faster than that in the Ang II
group at 1, 2, and 3min after reoxygenation; at 5 min after
reoxygenation, no signiﬁcant differences were observed. The
changes in the mean Amp ratio during the ﬁrst 5 min after
reoxygenation are illustrated in the right graph. The mean
Amp ratios R-1, R-2, and R-3 in the Ang II plus 5-HD group
were signiﬁcantly higher than those in the Ang II group,
indicating that the recovery of Amp ratio was more rapid inthe Ang II plus 5-HD group. At 5 min after reoxygenation, no
signiﬁcant difference was noted in the Amp ratio between
the Ang II and other groups.
4. Discussion
To assess the excitability and conductivity during the
super-acute phase of RA, RES was performed immediately
after reoxygenation, thereby simulating ventricular tachy-
cardia. The use of a DVD camera enabled the analysis of
the upstroke of successive APs within very short spans
of time.
The major results from this study are summarized here.
(1) In the control, the incidence of conduction block was
highest within the ﬁrst 10 s of RES and that of AT alternans
after conduction block was the highest from 10 to 20 s;
subsequently, 1:1 conduction was resumed after 40 s. (2)
The conduction block progressively increased during RES
under perfusion with Ang II, and its occurrence was sig-
niﬁcantly higher during the late stage of RES (40–60 s) in
the Ang II group than in the control, although the recovery
of APD50 progressed at the late stage of RES. (3) Ang II
induced conduction block, and AT alternans was suppressed
by adding AT1 receptor blocker (CV-11974) or mito-KATP
blocker (5-HD) to the perfusate after reoxygenation.
4.1. Problems in recording AT
When a small preparation is stimulated by a unipolar
electrode, electrical current is delivered simultaneously to
the whole preparation (ﬁeld stimulation). Under these
conditions, the conductive excitation cannot be measured
constantly. To overcome these problems, modiﬁed bipolar
electrodes devised by our group were used in the present
experiment, the details of which have been previously
reported [8]. Another difﬁculty in measuring the myocar-
dial conduction was an unexpected, quick, and large
systolic movement of the PPM. The circular tungsten wire
electrode used to record the EG was positioned gently on
the tip of the PPM to minimize this unexpected systolic
movement. According to the conﬁguration of the EG, we
determined whether a given excitation front progressed
through the PPM. The above procedures, if carried out
correctly, would enable the measurement of AT. The AT
was calculated as the sum of the time taken for myocar-
dial conduction through the PPM and the latent period
following electrical stimulation.
4.2. Ang II-induced conduction block during reoxygenation
In our study, the enhanced activation of Ang II receptor
under reoxygenation and RES possibly contributed to the
AT prolongation and conduction block [9,10]. Fig. 4B
shows that the incidence of conduction block was
the highest within the ﬁrst 20 s of RES and decreased
towards the end of RES in the control; this was similar to
tissue responses after rapid pacing without metabolic
inhibition [11]. Conversely, the incidence of conduction
block progressively increased after RES under Ang II.
During the late stage of RES (40–60 s), the occurrence of
conduction block was signiﬁcantly higher in the Ang II
Fig. 6. Activation time and action potential amplitude ratios from 1 to 5 min after reoxygenation. Light-gray areas indicate the period of perfusion of
simulated ischemic solution for 5 min. Dotted line: control group (n¼12); broken line: Ang II group (n¼10); gray line: Ang II plus CV-11974 group
(n¼10); black line: Ang II plus 5-HD group (n¼12). All measurements are shown in terms of mean and SD. nPo0.05, nnPo0.01, and nnnPo0.001, Ang II
vs. Ang II plus 5-HD; #Po0.05, ##Po0.01, Ang II vs. Ang II plus CV-11974. Abbreviations: Ang II: angiotensin II; Amp: amplitude of transmembrane action
potential; Amp ratio: ratio of Amp deﬁned as baseline Amp/Amp after simulated ischemia to reoxygenation; AT ratio: ratio of activation time deﬁned as
baseline AT/AT after simulated ischemia to reoxygenation; Is-5: 5 min after superfusion of simulated ischemic solution; RES: rapid electrical stimulation;
S-ischemia: simulated ischemia; R-1, R-2, R-3, R-4, and R-5 for 1, 2, 3, 4, and 5 min after reoxygenation.
D. Wakatsuki et al. / Journal of Arrhythmia 28 (2012) 26–3332group than in the control group (Po0.05) although there
was no signiﬁcant difference in APD50 during the late
stage of RES between both groups, as shown in Fig. 5. AT
alternans and conduction block at that stage were sup-
pressed by an AT1 blocker. Thus, this study demonstrates
that Ang II can play a major role in the appearance of
conduction block during the late phase of RES. Mat-
suyama et al. noted that the Ang II-induced conduction
block occurred in the left atrium in SHRIzm during RES,
without changes in Amp and dV/dt [8]; this ﬁnding is
consistent with our results. Furthermore, the restoration
of AT at the end of RES (R-1) was signiﬁcantly more
pronounced in the Ang II plus CV-11974 group than in the
control group and more pronounced in the control than in
the Ang II group, as shown in Fig. 6. This indicates that the
inhibitory action of the AT1 blocker on AT may be exerted
on not only exogenous but also endogenous Ang II
because both exogeneous and endogenous Ang II were
activated in the Ang II group, while only endogeneous Ang
II was activated in the control. This suggests that RAs
generated within 1 min after reperfusion are maintained
in the presence of Ang II since Ang II accelerates the
conduction block even during progressive recovery from
myocardial ischemia.
A major action of Ang II on ionic channels is the
activation of the L-type calcium channel, which contri-
butes to the transient prolongation of APD50. The prolon-
gation of APD50 results in the prolongation of the
refractory period of the heart. Besides its action on the
calcium channel, Ang II potentiates the slow component of
the delayed rectiﬁer Kþ current (IKs) via AT1 stimulation in
atrial myocytes, accompanied by a shortening of APD [12]
that may accelerate the elimination of conduction blockduring RES. These actions of Ang II on ion channels might
be responsible for its antiarrhythmic effects. Therefore, the
mechanism of Ang II-induced conduction block cannot be
explained by actions of the Ang II on ion channels.4.3. Effects of cell-to-cell impulse propagation
A previous study reported that Ang II did not suppress
cellular excitability assessed using strength–interval
curves, but the conductivity from cell-to-cell impulse
propagation can be reduced without accompanying
changes in the resting membrane potential or the ampli-
tude of AP in rat [13]. This implies that the effect of Ang II
on tissue conductivity does not depend on the opening of
voltage-dependent sodium channels, but on the reduction
of voltage-insensitive gap junction conductance [14–16].
Thus, it is conceivable that AT prolongation and block may
be induced by a decrease in gap junction conductance
during the upregulation of AT1 receptor. Additionally,
Naitoh et al. showed that in isolated rabbit hearts, the
opening of the mito-KATP channel activated extracellular
signal-regulated kinase (ERK1/2) via free radicals and that
this activation of ERK1/2 decreased gap junction perme-
ability during ischemia/reperfusion [17]. These results
may be consistent with our observations that AT prolon-
gation and conduction block are suppressed under 5-HD.
On the basis of our results, we suggest that AT1 receptor-
mediated opening of the mito-KATP channel is a possible
mechanism that promotes Ang II-induced RAs immedi-
ately after reperfusion [18]. Further studies are required to
understand the relationship between the Ang II-induced
conduction block and the opening of mito-KATP channels.
D. Wakatsuki et al. / Journal of Arrhythmia 28 (2012) 26–33 334.4. Clinical implications and limitations
This study intended to verify the direct action of Ang II
on cellular electrophysiological properties linked with
RA. As discussed above, electrophysiological properties
mediated by Ang II under reperfusion may promote or
maintain ventricular arrhythmias by a mechanism invol-
ving the induction of conduction delay and block chieﬂy
due to a decrease in gap-junction conductance, which
appeared even during progressive restoration after myo-
cardial ischemia. Hence, ARB may suppress RAs by elim-
inating Ang II-induced conduction delay, which might be
one of the mechanisms by which ARB reduces sudden
cardiac death in postinfarction patients [1].
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